Table 1 Baseline characteristics of study population according to diagnosis at the end of follow-up

All participants

29

(100)

21

(100)

4

(100)

2

(100)

 Males

17

(58.6)

10

(47.6)

2

(50.0)

1

(50.0)

 Females

12

(41.4)

11

(52.4)

2

(50.0)

1

(50.0)

  < 65 years

14

(48.3)

6

(28.6)

4

(100)

–

  ≥ 65 years

15

(51.7)

15

(71.4)

–

2

(100)

  < 8 years

11

(37.9)

5

(28.8)

–

2

(100)

 8–12 years

8

(27.6)

8

(38.1)

4

(100)

–

  ≥ 13 years

10

(34.5)

8

(38.1)

–

–

 Noncarriers

14

(48.3)

4

(19.0)

2

(50.0)

1

(50.0)

 Carriers

8

(27.6)

9

(42.9)

–

1

(50.0)

 Missing

7

(24.1)

8

(38.1)

2

(50.0)

–

Months of follow-up^a

44.4

(31.1–55.3)

35.5

(29.6–47.4)

43.1

–

38.5

–